α-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein e-deficient mice fed high-fat/low-cholesterol diet

被引:93
作者
Yi, Xianwen [1 ]
Maeda, Nobuyo [1 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
D O I
10.2337/db06-0251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Considerable evidence indicates that hyperglycemia increases oxidative stress and contributes to the increased incidence of atherosclerosis and cardiovascular complications in diabetic patients. To examine the effect of a-lipoic acid, a potent natural antioxidant, on atherosclerosis in diabetic mice, 3-month-old apolipoprotein (apo) E-deficient (apoE(-/-)) mice were made diabetic by administering streptozotocin (STZ). At 4 weeks after starting the STZ administration, a high-fat diet with or without alpha-lipoic acid (1.65 g/kg) was given to the mice and to nondiabetic apoE controls. At 20 weeks, markers of oxidative stress were significantly lower in both the diabetic apoE(-/-) mice and their nondiabetic apoE(-/-) controls with alpha-lipoic acid supplement than in those without it. Remarkably, alpha-lipoic acid completely prevented the increase in plasma total cholesterol, atherosclerotic lesions, and the general deterioration of health caused by diabetes. These protective effects of alpha-lipoic acid were accompanied by a reduction of plasma glucose and an accelerated recovery of insulin-producing cells in the pancreas, suggesting that part of its effects are attributable to protecting pancreatic beta-cells from damage. Our results suggest that dietary alpha-lipoic acid is a promising protective agent for reducing cardiovascular complications of diabetes.
引用
收藏
页码:2238 / 2244
页数:7
相关论文
共 47 条
[1]   The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid -: The SYDNEY trial [J].
Ametov, AS ;
Barinov, A ;
Dyck, PJ ;
Hermann, R ;
Kozlova, N ;
Litchy, WJ ;
Low, PA ;
Nehrdich, D ;
Novosadova, M ;
O'Brien, PC ;
Reljanovic, M ;
Samigullin, R ;
Schuette, K ;
Strokov, I ;
Tritschler, H ;
Wessel, K ;
Yakhno, N ;
Ziegler, D .
DIABETES CARE, 2003, 26 (03) :770-776
[2]   ANTICHOLESTEROL ACTIVITY OF ALPHA-LIPOIC ACID [J].
ANGELUCCI, L ;
MASCITELLICORIANDOLI, E .
NATURE, 1958, 181 (4613) :911-912
[3]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[4]   High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes [J].
Bursell, SE ;
Clermont, AC ;
Aiello, LP ;
Aiello, LM ;
Schlossman, DK ;
Feener, EP ;
Laffel, L ;
King, GL .
DIABETES CARE, 1999, 22 (08) :1245-1251
[5]   INHIBITION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN BLOOD-PLASMA BY CIGARETTE-SMOKE EXTRACT AND REACTIVE ALDEHYDES [J].
CHEN, C ;
LOO, G .
JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1995, 10 (03) :121-128
[6]   Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse [J].
Crawford, RS ;
Kirk, EA ;
Rosenfeld, ME ;
LeBoeuf, RC ;
Chait, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1506-1513
[7]   Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions [J].
Cyrus, T ;
Yao, YM ;
Rokach, J ;
Tang, LX ;
Praticò, D .
CIRCULATION, 2003, 107 (04) :521-523
[8]   Role of endothelial dysfunction in atherosclerosis [J].
Davignon, J ;
Ganz, P .
CIRCULATION, 2004, 109 (23) :27-32
[9]   SPECTROPHOTOMETRIC ASSAYS FOR THE ENZYMATIC-HYDROLYSIS OF THE ACTIVE METABOLITES OF CHLORPYRIFOS AND PARATHION BY PLASMA PARAOXONASE ARYLESTERASE [J].
FURLONG, CE ;
RICHTER, RJ ;
SEIDEL, SL ;
COSTA, LG ;
MOTULSKY, AG .
ANALYTICAL BIOCHEMISTRY, 1989, 180 (02) :242-247
[10]  
GANDY SE, 1983, DIABETOLOGIA, V24, P437